Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 10 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Turcot syndrome 1 Tongue Neoplasms 1 Thrombocythemia, Essential 1 Rhabdoid Tumor 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma 1 Locally Advanced Malignant Neoplasm 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophagitis 1

Interventions

Gemcitabine 679 130-nm albumin-bound paclitaxel 198 Fluorouracil 186 Oxaliplatin 175 Albumin-Bound Paclitaxel 151 Capecitabine 137 Leucovorin 131 Irinotecan 113 Radiotherapy 95 Taxes 83 pembrolizumab 80 Cisplatin 72 Erlotinib Hydrochloride 69 Radiosurgery 67 Nivolumab 56 Bevacizumab 54 Drug Therapy 52 Cyclophosphamide 49 Magnetic Resonance Spectroscopy 46 folfirinox 42 Docetaxel 41 Cetuximab 40 Specimen Handling 37 irinotecan sucrosofate 36 S 1 (combination) 36 Biopsy 31 Radiation 29 Paclitaxel 29 Ipilimumab 27 durvalumab 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Neoplasms × Induction Chemotherapy × Clear all

NCT01827553 2024-04-11

CONKO-007

University of Erlangen-Nürnberg Medical School

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡